Literature DB >> 9164800

Universal newborn hearing screenings: a three-year experience.

L Barsky-Firkser1, S Sun.   

Abstract

OBJECTIVE: To perform hearing screenings on all newborns before hospital discharge, using auditory brainstem evoked responses with analysis of time, cost, and failure rates to evaluate and determine the screening practicality.
METHOD: Over a 3-year period from January 1, 1993 to December 31, 1995, auditory brainstem evoked response screenings were performed on 15 749 infants born at Saint Barnabas Medical Center, Livingston, New Jersey, before their hospital discharge by certified/licensed audiologists. The auditory brainstem evoked response screenings were conducted using the Nicolet Compass Evoked Potential System.
RESULTS: A 3-year experience of testing 15 749 infants proved to be a cost-effective program with costs less than $30.00/baby. To date, 46 babies have been identified with bilateral sensorineural hearing loss and 6 babies with unilateral sensorineural hearing loss.
CONCLUSIONS: The universal newborn hearing screening program at Saint Barnabas Medical Center has proved to be effective, beneficial, and necessary for an institution with more than 5000 births, annually. Early identification of hearing loss has resulted in infants receiving early intervention, and the screening program has provided education and follow-up services to both parents and physicians.

Entities:  

Mesh:

Year:  1997        PMID: 9164800     DOI: 10.1542/peds.99.6.e4

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  Potentiation of Chemical Ototoxicity by Noise.

Authors:  Peter S Steyger
Journal:  Semin Hear       Date:  2009-02-01

2.  Evaluation of an automated auditory brainstem response in a multi-stage infant hearing screening.

Authors:  Luca Guastini; Renzo Mora; Massimo Dellepiane; Valentina Santomauro; Massimiliano Mora; Antonio Rocca; Angelo Salami
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-11       Impact factor: 2.503

3.  Unilateral hearing loss in children: speech-language and school performance.

Authors:  J E C Lieu
Journal:  B-ENT       Date:  2013       Impact factor: 0.082

4.  Benefits of Cochlear Implantation in Childhood Unilateral Hearing Loss (CUHL Trial).

Authors:  Kevin D Brown; Margaret T Dillon; Lisa R Park
Journal:  Laryngoscope       Date:  2021-09-20       Impact factor: 2.970

5.  Effectiveness of a TEOAE-based screening program. Can a patient-tracking system effectively be organized using modern information technology and central data management?

Authors:  W Delb; D Merkel; K Pilorget; J Schmitt; P K Plinkert
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-08-28       Impact factor: 2.503

6.  Longitudinal study of children with unilateral hearing loss.

Authors:  Judith E C Lieu; Nancy Tye-Murray; Qiang Fu
Journal:  Laryngoscope       Date:  2012-08-01       Impact factor: 3.325

7.  Role of Otoacoustic Emission Test in Neonatal Screening at Tertiary Center.

Authors:  Shiv Kumar Raghuwanshi; Aditya Gargava; Vikram Kulkarani; Ajit Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-02-07

8.  Newborn genetic screening for hearing impairment: a population-based longitudinal study.

Authors:  Chen-Chi Wu; Ching-Hui Tsai; Chia-Cheng Hung; Yin-Hung Lin; Yi-Hsin Lin; Fang-Li Huang; Po-Nien Tsao; Yi-Ning Su; Yungling Leo Lee; Wu-Shiun Hsieh; Chuan-Jen Hsu
Journal:  Genet Med       Date:  2016-06-16       Impact factor: 8.822

9.  Newborn genetic screening for hearing impairment: a preliminary study at a tertiary center.

Authors:  Chen-Chi Wu; Chia-Cheng Hung; Shin-Yu Lin; Wu-Shiun Hsieh; Po-Nien Tsao; Chien-Nan Lee; Yi-Ning Su; Chuan-Jen Hsu
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

10.  Economic evaluation of newborn hearing screening: modelling costs and outcomes.

Authors:  Franz Hessel; Eva Grill; Petra Schnell-Inderst; Uwe Siebert; Silke Kunze; Andreas Nickisch; Hubertus von Voss; Jürgen Wasem
Journal:  Ger Med Sci       Date:  2003-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.